Inadequate Uptake of USPSTF-Recommended Low Dose CT Lung Cancer Screening.
1Biotheranostics, Inc/A Hologic Company, San Diego, CA, USA.
Journal of Primary Care & Community Health
|February 24, 2024
Summary
Lung cancer screening (LCS) is underutilized, especially in high-risk groups, and shows disparities. Improving knowledge and addressing barriers are key to increasing screening rates for eligible individuals.
Area of Science:
- Primary care
- Public health
- Preventive medicine
Background:
- Lung cancer screening (LCS) is recommended for high-risk individuals.
- Current LCS utilization is suboptimal, with significant disparities among eligible populations.
- Understanding barriers to LCS is crucial for improving uptake.
Purpose of the Study:
- To review recent findings on lung cancer screening (LCS).
- To explore clinician and patient knowledge regarding LCS rationale.
- To identify strategies for increasing LCS uptake and reducing disparities.
Main Methods:
- Review of 2023 studies from the Journal of Primary Care and Community Health.
- Analysis of recent reports on lung cancer screening (LCS).
- Discussion of USPSTF recommendations, provider barriers, patient perspectives, and shared decision-making (SDM).
Main Results:
- Significant underutilization of LCS noted, particularly in specific high-risk populations.
- Persistent disparities in LCS access and utilization across different demographic groups.
- Barriers exist for primary care providers and eligible individuals regarding LCS.
Conclusions:
- Improving knowledge of LCS rationale among clinicians and patients is essential.
- Addressing provider and patient barriers, alongside promoting shared decision-making (SDM), can enhance LCS rates.
- Strategies are needed to ensure equitable access to LCS for all eligible individuals.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
408
